Delivery Order SPE2DX22D0010-SPE2D824FQD62
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$8.6K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VYVANSE 60 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $1,783.60 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of VYVANSE 70 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $1,927.45 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 24, 2025, with an ultimate completion date of January 27, 2025. The contract is not designated as a set-aside procurement. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $2,358.08, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 31, 2024 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of VYVANSE 60 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 17, 2024, with a ceiling value of $1,724.00 and a completion date of September 18, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a...
This federal contract award is for the delivery of VYVANSE 20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $1,776.74 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,994.76 firm fixed-price delivery order is for the supply of VYVANSE 30 MG CAPSULE 100S, with a period of performance through October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of VYVANSE 20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $1,783.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $2,103.27 and a completion date of February 29, 2024. No set-aside designation was used for this award....
This federal contract award is for the delivery of VYVANSE 10 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $1,293.00. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 4, 2024. This award is not designated as a set-aside contract. The contract appears to...
This federal contract award is for the delivery of VYVANSE 40 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $5,138.97 firm fixed-price delivery order was awarded on January 30, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of January 31, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...